CLINICAL_TRIALS
trial_result
· 2021-03-18
Clinical Trial Update: A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy [Phase 4]
Summary
Phase 4 trial evaluating anti-inflammatory effects of Lastacaft in allergic conjunctivitis; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ORA, Inc. | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2021-03-18